Airway transplantation

A debate worth having?

Martin Birchall, Paolo Macchiarini

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Laryngeal and tracheal transplantation have been proposed as treatments for irreversible airway disease for many years. Despite much research, there has only been one true laryngeal transplant reported. Although this was in many ways a success, several barriers remain before full clinical trials. There are issues over patient selection, reinnervation, immunosuppression, and cost-benefit. For the trachea, where finely tuned neuromuscular activity is not an issue, tissue-engineering probably represents the future. This overview discusses the arguments for and against laryngeal and tracheal transplantation and suggests ways of overcoming these barriers.

Original languageEnglish (US)
Pages (from-to)1075-1080
Number of pages6
JournalTransplantation
Volume85
Issue number8
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Transplantation
Tissue Engineering
Trachea
Immunosuppression
Patient Selection
Cost-Benefit Analysis
Clinical Trials
Transplants
Research
Therapeutics

Keywords

  • Laryngeal transplantation
  • Mucosal immunity
  • Reinnervation
  • Tissue engineering
  • Tracheal transplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Airway transplantation : A debate worth having? / Birchall, Martin; Macchiarini, Paolo.

In: Transplantation, Vol. 85, No. 8, 04.2008, p. 1075-1080.

Research output: Contribution to journalArticle

Birchall, M & Macchiarini, P 2008, 'Airway transplantation: A debate worth having?', Transplantation, vol. 85, no. 8, pp. 1075-1080. https://doi.org/10.1097/TP.0b013e31816a10e4
Birchall, Martin ; Macchiarini, Paolo. / Airway transplantation : A debate worth having?. In: Transplantation. 2008 ; Vol. 85, No. 8. pp. 1075-1080.
@article{365b9b2de063477cbb3c57930a8c72bc,
title = "Airway transplantation: A debate worth having?",
abstract = "Laryngeal and tracheal transplantation have been proposed as treatments for irreversible airway disease for many years. Despite much research, there has only been one true laryngeal transplant reported. Although this was in many ways a success, several barriers remain before full clinical trials. There are issues over patient selection, reinnervation, immunosuppression, and cost-benefit. For the trachea, where finely tuned neuromuscular activity is not an issue, tissue-engineering probably represents the future. This overview discusses the arguments for and against laryngeal and tracheal transplantation and suggests ways of overcoming these barriers.",
keywords = "Laryngeal transplantation, Mucosal immunity, Reinnervation, Tissue engineering, Tracheal transplantation",
author = "Martin Birchall and Paolo Macchiarini",
year = "2008",
month = "4",
doi = "10.1097/TP.0b013e31816a10e4",
language = "English (US)",
volume = "85",
pages = "1075--1080",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Airway transplantation

T2 - A debate worth having?

AU - Birchall, Martin

AU - Macchiarini, Paolo

PY - 2008/4

Y1 - 2008/4

N2 - Laryngeal and tracheal transplantation have been proposed as treatments for irreversible airway disease for many years. Despite much research, there has only been one true laryngeal transplant reported. Although this was in many ways a success, several barriers remain before full clinical trials. There are issues over patient selection, reinnervation, immunosuppression, and cost-benefit. For the trachea, where finely tuned neuromuscular activity is not an issue, tissue-engineering probably represents the future. This overview discusses the arguments for and against laryngeal and tracheal transplantation and suggests ways of overcoming these barriers.

AB - Laryngeal and tracheal transplantation have been proposed as treatments for irreversible airway disease for many years. Despite much research, there has only been one true laryngeal transplant reported. Although this was in many ways a success, several barriers remain before full clinical trials. There are issues over patient selection, reinnervation, immunosuppression, and cost-benefit. For the trachea, where finely tuned neuromuscular activity is not an issue, tissue-engineering probably represents the future. This overview discusses the arguments for and against laryngeal and tracheal transplantation and suggests ways of overcoming these barriers.

KW - Laryngeal transplantation

KW - Mucosal immunity

KW - Reinnervation

KW - Tissue engineering

KW - Tracheal transplantation

UR - http://www.scopus.com/inward/record.url?scp=42549106892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549106892&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31816a10e4

DO - 10.1097/TP.0b013e31816a10e4

M3 - Article

VL - 85

SP - 1075

EP - 1080

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 8

ER -